The lateral lymph node metastasis rate in this group of patients is also high (70%, 7/10), and they can be classified as a high-risk group clinically, but other clinical characteristics are significantly different from the BRAF+TERT group of patients (Figure 6B). The gene discussed is BRAF; the disease is metastatic malignant neoplasm in the lymph nodes.